News

Off the Grid: Sally breaks down USA TODAY's daily crossword, There Are No Bad Questions
Explore daily insights on the USA TODAY crossword puzzle by . Uncover expert takes and answers in our crossword blog.
The Manila Times32m
Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC
Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% ...
F. Hoffmann-La Roche Ltd: Roche presents new insights in Alzheimer's disease research across its diagnostics and pharmaceutical portfolios at AAIC
Trontinemab's Phase Ib/IIa Brainshuttle AD study continues to show rapid and robust clearance of amyloid plaques, with 91% becoming amyloid PET negative and ARIA-E remaining Design of the Phase III TR ...